In our weekly check, Protagonist Therapeutics, Inc. is graded B (A to F). Of 18 checks on debt, profit, cash flow and trend: 12 pass, warnings: 4, red flags: 2.
Sector: Healthcare · Biotechnology
Next earnings report: 2026-11-05
ARWR · KYMR · AXSM · KRYS · TGTX · PRAX
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks graded D or F lost a third of their value 2-3 times as often as those graded A or B.
Updated 2026-10-03